BIOSCIENCE NEUTRACEUTICALS, INC.
company.status.inactiveCIK 1555995fmd_152ZZ2K8AC4NG46E5BR0N4M7JYRetail Trade · Retail-Miscellaneous RetailTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2019, 29 periods
Latest annual · FY2017
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (1)
Latest quarter · Q4 FY2019
Millions- Operating income
- 0
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2017
- n/m
- Net income, 5 yearsFY2014 to FY2019
- n/m
BIOSCIENCE NEUTRACEUTICALS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Operating income | -$459,750 | -$36,300 | 10-K 2020-03-30 · proof | |
| Net income | -$626,046 | -$73,538 | 10-K 2020-03-30 · proof | |
| Cash from operating activities | -$37,140 | -$47,012 | 10-K 2020-03-30 · proof | |
| Total liabilities | $244,142 | $191,320 | +27.6% | 10-K 2020-03-30 · proof |
- What was BIOSCIENCE NEUTRACEUTICALS, INC.'s operating income in fiscal 2019?
- BIOSCIENCE NEUTRACEUTICALS, INC. reported operating income of -$459,750 for fiscal 2019 (the year ended Dec 31, 2019), against -$36,300 the year before. Source: the 10-K filed with the SEC on Mar 30, 2020. SEC
- What was BIOSCIENCE NEUTRACEUTICALS, INC.'s net income in fiscal 2019?
- BIOSCIENCE NEUTRACEUTICALS, INC. reported net income of -$626,046 for fiscal 2019 (the year ended Dec 31, 2019), against -$73,538 the year before. Source: the 10-K filed with the SEC on Mar 30, 2020. SEC
- What was BIOSCIENCE NEUTRACEUTICALS, INC.'s cash from operating activities in fiscal 2019?
- BIOSCIENCE NEUTRACEUTICALS, INC. reported cash from operating activities of -$37,140 for fiscal 2019 (the year ended Dec 31, 2019), against -$47,012 the year before. Source: the 10-K filed with the SEC on Mar 30, 2020. SEC
- What are BIOSCIENCE NEUTRACEUTICALS, INC.'s total liabilities?
- As of Dec 31, 2019, BIOSCIENCE NEUTRACEUTICALS, INC. reported total liabilities of $244,142, against $191,320 a year earlier (+27.6%). Source: the 10-K filed with the SEC on Mar 30, 2020. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1555995&period_type=annual&limit=5"Information only, not investment advice.